Pfizer
delivered a solid set of first-quarter results, with earnings largely in line with analysts’ estimates and revenue far ahead of expectations. There’s more good news: Amid speculation that Covid-19 sales may fall short this year, the pharma giant reaffirmed its 2023 outlook.
Dell Technologies Inc. (DELL) Stock Forecasts
SummaryAfter trading as a public company for 25 years, Dell Inc. went private in October 2013; acquired EMC Corp. in...